Month: November 2017


Highlights from SITC 2017

It’s been an exciting and productive annual meeting for the Society for Immunotherapy of Cancer (SITC) 2017, full of ground-breaking science to share when back in the lab. For those of you who weren’t able to attend, mark your calendars...

/ November 29, 2017

Top 5 reasons why nSolver 4.0 and Advanced Analysis 2.0 will change your (data analysis) life

Your data doesn’t fit in a box. Gone are the days of assay-specific data analysis. nSolver 4.0 is analyte focused and less assay restricted. This means that any combination of analytes you can dream up is supported. Customize your experiment...

/ November 22, 2017

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such as multiple myeloma and lymphoma. His research centers on the...

/ November 16, 2017

Moving Toward the Clinic- Leveraging Xenograft Models for Preclinical Anti-Cancer Studies

The use of cancer cell lines for in vitro studies of anti-cancer agents remains a primary component of preclinical drug development. These studies, however, struggle with significant pitfalls given the unique biology of cancer cell lines and the artificial assay...

/ November 2, 2017